158 related articles for article (PubMed ID: 34764048)
21. Development of urological cancers in renal transplant recipients: 30-year experience at the Frankfurt Transplant Center.
Tsaur I; Karalis A; Probst M; Blaheta RA; Scheuermann EH; Gossmann J; Kachel HG; Hauser IA; Jonas D; Obermüller N
Cancer Sci; 2010 Nov; 101(11):2430-5. PubMed ID: 20707803
[TBL] [Abstract][Full Text] [Related]
22. Development of urologic de novo malignancies after renal transplantation.
Hevia V; Gómez V; Díez Nicolás V; Alvarez S; Gómez Del Cañizo C; Galeano C; Gomis A; García-Sagredo JM; Marcen R; Burgos FJ
Transplant Proc; 2014; 46(1):170-5. PubMed ID: 24507046
[TBL] [Abstract][Full Text] [Related]
23. High cumulative incidence of urinary tract transitional cell carcinoma after kidney transplantation in Taiwan.
Wu MJ; Lian JD; Yang CR; Cheng CH; Chen CH; Lee WC; Shu KH; Tang MJ
Am J Kidney Dis; 2004 Jun; 43(6):1091-7. PubMed ID: 15168390
[TBL] [Abstract][Full Text] [Related]
24. Associations of urological malignancies with renal progression and mortality in advanced chronic kidney disease: a propensity-matched cohort study.
Chinnadurai R; Clarke NW; Kalra PA
BMC Nephrol; 2020 May; 21(1):202. PubMed ID: 32471368
[TBL] [Abstract][Full Text] [Related]
25. The candidate for renal transplantation work up: medical, urological and oncological evaluation.
Cabello Benavente R; Quicios Dorado C; López Martin L; Simón Rodríguez C; Charry Gónima P; González Enguita C
Arch Esp Urol; 2011 Jun; 64(5):441-60. PubMed ID: 21705817
[TBL] [Abstract][Full Text] [Related]
26. De novo malignancies after kidney transplantation.
Hung YM; Chou KJ; Hung SY; Chung HM; Chang JC
Urology; 2007 Jun; 69(6):1041-4. PubMed ID: 17572182
[TBL] [Abstract][Full Text] [Related]
27. Urological Cancers and Kidney Transplantation: a Literature Review.
Hernández-Gaytán CA; Rodríguez-Covarrubias F; Castillejos-Molina RA; Hernández-Porras A; Tobia I; Dubin JM; Autrán-Gómez AM
Curr Urol Rep; 2021 Dec; 22(12):62. PubMed ID: 34913107
[TBL] [Abstract][Full Text] [Related]
28. Urologic de novo malignancies after kidney transplantation: a single center experience.
Karczewski M; Czapiewski W; Karczewski J
Transplant Proc; 2012 Jun; 44(5):1293-7. PubMed ID: 22664003
[TBL] [Abstract][Full Text] [Related]
29. Renal cell carcinoma (RCC) arising in native kidneys of dialyzed and transplant patients: are they different entities?
Gigante M; Neuzillet Y; Patard JJ; Tillou X; Thuret R; Branchereau J; Timsit MO; Terrier N; Boutin JM; Sallusto F; Karam G; Barrou B; Chevallier D; Mazzola CR; Delaporte V; Doeffler A; Kleinclauss F; Badet L; ;
BJU Int; 2012 Dec; 110(11 Pt B):E570-3. PubMed ID: 22726451
[TBL] [Abstract][Full Text] [Related]
30. Intermediate-term oncological outcomes of hand-assisted laparoscopic versus open bilateral nephroureterectomy for dialysis and kidney transplant patients with upper urinary tract urothelial carcinoma.
Tai HC; Lai MK; Chung SD; Huang KH; Chueh SC; Yu HJ
J Endourol; 2009 Jul; 23(7):1139-44. PubMed ID: 19530901
[TBL] [Abstract][Full Text] [Related]
31. Bladder recurrence after radical nephroureterectomy: predictors and impact on oncological outcomes.
Elalouf V; Xylinas E; Klap J; Pignot G; Delongchamps NB; Saighi D; Peyromaure M; Flam T; Zerbib M
Int J Urol; 2013 Nov; 20(11):1078-83. PubMed ID: 23521657
[TBL] [Abstract][Full Text] [Related]
32. [Urothelial carcinoma in kidney transplant recipients and candidates: The French guidelines from CTAFU].
Boissier R; Thuret R; Prudhomme T; Verhoest G; Bessede T; Branchereau J; Goujon A; Drouin S; Boutin JM; Neuzillet Y; Roupret M; Méjean A; Timsit MO
Prog Urol; 2021 Jan; 31(1):31-38. PubMed ID: 33423744
[TBL] [Abstract][Full Text] [Related]
33. Sex difference for urologic malignancy risk in uremic patients after kidney transplantation: a population-based study.
Hwang JC; Jiang MY; Lu YH; Weng SF
Transplantation; 2015 Apr; 99(4):818-22. PubMed ID: 25208323
[TBL] [Abstract][Full Text] [Related]
34. De Novo Urologic Malignancies in Renal Transplant Recipients.
Antunes H; Tavares-da-Silva E; Oliveira R; Carvalho J; Parada B; Bastos C; Figueiredo A
Transplant Proc; 2018 Jun; 50(5):1348-1354. PubMed ID: 29753463
[TBL] [Abstract][Full Text] [Related]
35. Association between urologic malignancies and end-stage renal disease: A meta-analysis.
Kompotiatis P; Thongprayoon C; Manohar S; Cheungpasitporn W; Gonzalez Suarez ML; Craici IM; Mao MA; Herrmann SM
Nephrology (Carlton); 2019 Jan; 24(1):65-73. PubMed ID: 29236344
[TBL] [Abstract][Full Text] [Related]
36. Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma.
Milojevic B; Djokic M; Sipetic-Grujicic S; Grozdic Milojevic I; Vuksanovic A; Nikic P; Vukovic I; Djordjevic D; Bumbasirevic U; Tulic C
Urol Oncol; 2013 Nov; 31(8):1615-20. PubMed ID: 22521771
[TBL] [Abstract][Full Text] [Related]
37. De novo urothelial carcinoma in kidney transplant patients with end-stage aristolochic acid nephropathy in China.
Yuan M; Shi YB; Li ZH; Xia M; Ji GZ; Xu GX; Han Y
Transplant Proc; 2009 Jun; 41(5):1619-23. PubMed ID: 19545692
[TBL] [Abstract][Full Text] [Related]
38. A Novel Risk-based Approach Simulating Oncological Surveillance After Radical Nephroureterectomy in Patients with Upper Tract Urothelial Carcinoma.
Shigeta K; Kikuchi E; Abe T; Hagiwara M; Ogihara K; Anno T; Umeda K; Baba Y; Sanjo T; Shojo K; Mikami S; Mizuno R; Oya M
Eur Urol Oncol; 2020 Dec; 3(6):756-763. PubMed ID: 31395480
[TBL] [Abstract][Full Text] [Related]
39. The Role of Opioids and Their Receptors in Urological Malignancy: A Review.
Lec PM; Lenis AT; Golla V; Brisbane W; Shuch B; Garraway IP; Reiter RE; Chamie K
J Urol; 2020 Dec; 204(6):1150-1159. PubMed ID: 32516030
[TBL] [Abstract][Full Text] [Related]
40. Urological evaluation prior to renal transplantation.
Power RE; Hickey DP; Little DM
Transplant Proc; 2004 Dec; 36(10):2962-7. PubMed ID: 15686671
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
